
"I was delighted to take part in a clinical trial as it has the potential to really help others in the future.”
This study looked at how a vaccine called TroVax affects the immune system in people who have bowel cancer that has spread to another part of the body.
Doctors can treat bowel cancer that has spread (advanced bowel cancer) with chemotherapy. But researchers are looking for ways to improve current .
If you have cancer, your immune system tries to attack and kill the cancer cells. Treatments such as TroVax may help the immune system to do this. But other cells in your body can stop your immune system attacking the cancer cells.
Researchers wanted to find out if a chemotherapy drug called cyclophosphamide can help get rid of cells that stop the immune system attacking cancer cells.
The main aim of this study was to see if there is a difference in how well your immune system responds to bowel cancer (the ) when you have TroVax or cyclophosphamide, or both.
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Dr Andrew Godkin
Experimental Cancer Medicine Centre (ECMC)
Haematology Clinical Trials Unit University of Cardiff
NIHR Clinical Research Network: Cancer
Freephone 0808 800 4040
"I was delighted to take part in a clinical trial as it has the potential to really help others in the future.”